Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU7-143P** is classified as a *pseudogene* of the U7 small nuclear RNA (U7 snRNA) family. The functional U7 snRNA is a small nuclear RNA essential for the 3'-end processing of replication-dependent histone pre-mRNA as part of the U7 small nuclear ribonucleoprotein (snRNP) complex[1][3]. However, pseudogenes like RNU7-143P are genomic sequences that share high sequence similarity to the parent U7 snRNA gene but do not produce functional RNA due to mutations or truncations typical of reverse-transcribed pseudogenes[7]. While the bona fide U7 snRNA is required for histone pre-mRNA processing and indirectly influences chromatin biology, pseudogenes such as RNU7-143P are generally not transcribed or translated into functional molecules and lack known biological or disease-relevant functions in humans[4][7]. There are no known drugs targeting RNU7-143P, nor is it a biomarker, therapeutic target, or associated with safety concerns. **Key notes:** - **RNU7-143P** is not a functional RNA or protein, but a pseudogene, and not a therapeutic target[7]. - Related entries (like RNU7-1 or RNU7-14P) represent other pseudogenes or the functional gene, but RNU7-143P itself is characterized as a non-functional copy[7]. - There is nothing to suggest a disease or biomarker role for RNU7-143P, and current evidence suggests it does not encode a functional RNA or protein product. **Summary of issues:** - This is not a functional therapeutic target; it is a pseudogene, meaning it does not produce active RNA or protein and is not druggable. - It is likely being mistaken for the functional U7 small nuclear RNA gene (RNU7-1 or U7 snRNA), but RNU7-143P is non-functional[7]. - Many such pseudogenes exist for snRNAs, but these are generally unexpressed and lack known biological functions[4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 143 pseudogene (RNU7-143P).